Latest Dividend News

National Australia Bank’s half year to March 2026 saw revenue climb 8.7% to $11.16 billion while net profit dropped 19.3%, hit by a $949 million accelerated software amortisation. Excluding this, cash earnings edged 2.3% higher, underpinned by strong business banking growth and cautious credit provisioning amid geopolitical uncertainty.

Bank of Queensland has finalised the sale of its equipment finance portfolio to Challenger for $3.62 billion, marking a pivotal step in its strategic transformation. The transaction sets the stage for potential shareholder returns through a buyback and special dividend, pending approvals.

Kina Securities has successfully closed an oversubscribed PGK 235 million subordinated bond, set to list on the PNGX Debt Market on 6 May 2026, offering a fixed 7.55% coupon over ten years.

Fat Prophets Global Contrarian Fund (ASX: FPC) has launched an on-market buy-back of its ordinary shares, set to run from May 2026 to May 2027, signalling a fresh phase in its capital management strategy.

Sequoia Financial Group has called off the sale of its InterPrac subsidiary to Conquest Investment Partners, citing unmet conditions and changed circumstances that made completion unviable. The company will now explore alternative strategic paths for InterPrac.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

NH3 Clean Energy’s WAH2 project is projected to deliver substantial economic and environmental benefits, including a $7.3 billion GDP uplift and 13.5 million tonnes of CO2 emissions avoided, underpinning its push for government-backed concessional financing.

Resmed delivered a robust Q3 FY2026 with 11% revenue growth, margin expansion, and a 21% jump in non-GAAP EPS, while announcing a new U.S. distribution centre and a $0.60 dividend.

ANZ Group Holdings Limited posted a 14% rise in cash profit for 1H26 to AUD 3.78 billion, driven by cost reductions and steady revenue, while declaring an 83-cent interim dividend with 75% franking.

Kingsgate Consolidated sustained robust production at Chatree with a fifth straight quarter exceeding 20,000 ounces of gold, while achieving a record AISC margin and boosting cash reserves to A$213 million.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Jupiter Mines reported a 49% quarter-on-quarter EBITDA increase driven by higher manganese prices, despite cost pressures from exchange rates and Middle East conflict-related freight hikes.